(19)
(11) EP 3 677 261 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.07.2023 Bulletin 2023/29

(45) Mention of the grant of the patent:
07.06.2023 Bulletin 2023/23

(21) Application number: 19209258.3

(22) Date of filing: 23.09.2011
(51) International Patent Classification (IPC): 
A61M 25/01(2006.01)
A61K 31/185(2006.01)
A61P 9/00(2006.01)
A61P 25/00(2006.01)
A61K 31/195(2006.01)
A61K 31/10(2006.01)
A61K 31/155(2006.01)
A61K 31/661(2006.01)
A61K 38/17(2006.01)
 A61K 31/19(2006.01)
A61K 9/08(2006.01)
A61P 1/00(2006.01)
A61K 38/57(2006.01)
A61K 31/24(2006.01)
A61K 31/145(2006.01)
A61K 31/216(2006.01)
A61K 31/765(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/08; A61K 31/185; A61K 31/19; A61K 31/765; A61K 31/195; A61K 31/24; A61K 38/57; A61K 31/10; A61K 31/145; A61K 31/155; A61K 31/216; A61K 31/661; A61K 38/1722; A61P 1/00; A61P 25/00; A61P 9/00

(54)

ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH

VERABREICHUNG VON SERINPROTEASEHEMMERN IN DEN MAGEN

ADMINISTRATION D'INHIBITEURS DE LA PROTÉASE SÉRINE DANS L'ESTOMAC

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 23.09.2010 US 38579810 P
30.08.2011 US 201161529052 P

(43) Date of publication of application:
08.07.2020 Bulletin 2020/28

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11827628.6 / 2624823

(73) Proprietors:
  • Leading BioSciences, Inc.
    Carlsbad, CA 92008 (US)
  • The Regents of the University of California
    Oakland, CA 94607 (US)

(72) Inventors:
  • SCHMID-SCHOENBEIN, Geert
    La Jolla, CA 92037 (US)
  • LEE, Andrew
    Taipei (TW)
  • WEI, Jeng
    Taipei (TW)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)


(56) References cited: : 
WO-A1-01/37854
WO-A2-2009/132149
 WO-A1-2009/045543
   
  • DELANO FRANK A ET AL: "Pancreatic Digestive Enzyme Blockade in the Intestine Increases Survival After Experimental Shock", SCIENCE TRANSLATIONAL MEDICINE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (A A A S), US, vol. 5, no. 169, 23 January 2013 (2013-01-23), page 169ra11, XP009520455, ISSN: 1946-6234, DOI: 10.1126/SCITRANSLMED.3005046
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).